Rethinking the Customer Engagement Model in Japan for COVID-19 and Beyond L.E.K. Consulting Read more
Related Practice Life Sciences & Pharma Unlike many other markets in the world, Japan had until very recently been driven by ‘share-of-voice’, with market development and patient share being largely sensitive to sales activity. 01022024160132
Published Articles Sustainability To Meet Decarbonization Targets, Master The Circular Economy July 9, 2024
Executive Insights Diagnostics, Tools and Personalized Medicine Commercial Excellence in Life Sciences Tools and Services Companies April 8, 2024
Executive Insights Mental and Behavioral Health Psychedelics and Psychotherapy: A Treatment Paradigm for the Future? March 27, 2024
Executive Insights Life Sciences & Pharma Navigating the Shifting Landscape in Life Sciences: Trends and Implications July 31, 2023